CNX Therapeutics, a European specialty pharmaceutical company, has announced the permanent appointment of Lucy Ralph as Chief People and Transformation Officer.
Ralph joined CNX in May 2026 as Interim Chief People Officer. She now moves into the role on a permanent basis, with an expanded remit that adds organisational transformation to her existing People responsibilities.
In this broader role, Ralph will continue to lead CNX’s people function while taking on responsibility for organisational transformation, partnering with CEO Guy Clark and the wider Executive Committee to ensure CNX is set up to scale effectively as it grows across Europe.
Ralph brings extensive HR leadership, transformation and private equity experience to the role. She spent close to 14 years at Evaluate, rising to Chief Human Resources Officer in 2018. Following a major private equity merger, she went on to hold the dual role of Chief Administration Officer at Norstella from 2022.
Guy Clark, CEO of CNX Therapeutics, said: “Lucy has brought rigour, energy and focus to how we lead our people through a period of growth, and her appointment as Chief People and Transformation Officer reflects the confidence we have in her to help shape CNX’s next chapter.”
Ralph added: “CNX has built an extraordinary foundation over the last five years, but what excites me most is the runway ahead. My focus is on ensuring our people and transformation agenda directly powers our commercial performance – building a high-velocity culture that drives measurable growth and keeps CNX moving fast.”